Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Related Articles by Review for PubMed (Select 21816222)

1.

17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.

Li M, Zhang Z, Sun W, Koehler RC, Huang J.

Neurobiol Dis. 2011 Dec;44(3):277-83. doi: 10.1016/j.nbd.2011.07.004. Epub 2011 Jul 18.

2.

Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders.

Armstead WM, Ganguly K, Kiessling JW, Riley J, Chen XH, Smith DH, Stein SC, Higazi AA, Cines DB, Bdeir K, Zaitsev S, Muzykantov VR.

J Neurochem. 2010 Apr;113(2):303-12. Review.

3.

Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.

Hess DC, Fagan SC.

Pharmacotherapy. 2010 Jul;30(7 Pt 2):55S-61S. doi: 10.1592/phco.30.pt2.55S. Review.

5.

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.

Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH.

Stroke. 2004 Nov;35(11 Suppl 1):2726-30. Epub 2004 Sep 30. Review.

6.

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

Yepes M, Roussel BD, Ali C, Vivien D.

Trends Neurosci. 2009 Jan;32(1):48-55. doi: 10.1016/j.tins.2008.09.006. Epub 2008 Oct 27. Review.

PMID:
18963068
7.

Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?

Niego B, Medcalf RL.

J Cereb Blood Flow Metab. 2014 Aug;34(8):1283-96. doi: 10.1038/jcbfm.2014.99. Epub 2014 Jun 4. Review.

PMID:
24896566
8.

Therapeutic approaches to vascular protection in ischemic stroke.

Yamashita T, Abe K.

Acta Med Okayama. 2011 Aug;65(4):219-23. Review.

9.

Role of tissue-type plasminogen activator in ischemic stroke.

Suzuki Y.

J Pharmacol Sci. 2010;113(3):203-7. Epub 2010 Jun 29. Review.

10.

Role of tissue plasminogen activator in acute ischemic stroke.

Hatcher MA, Starr JA.

Ann Pharmacother. 2011 Mar;45(3):364-71. doi: 10.1345/aph.1P525. Epub 2011 Mar 8. Review.

PMID:
21386027
11.

Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

Adibhatla RM, Hatcher JF.

CNS Neurol Disord Drug Targets. 2008 Jun;7(3):243-53. Review.

12.

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke.

Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM.

Vasc Health Risk Manag. 2014 Feb 24;10:75-87. doi: 10.2147/VHRM.S39213. eCollection 2014. Review.

13.

The neurotoxicity of tissue plasminogen activator?

Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM.

J Cereb Blood Flow Metab. 2004 Sep;24(9):945-63. Review.

PMID:
15356416
14.

Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.

Chaturvedi M, Kaczmarek L.

Mol Neurobiol. 2014 Feb;49(1):563-73. doi: 10.1007/s12035-013-8538-z. Epub 2013 Sep 12. Review.

15.

Neuroprotective action of acute estrogens: animal models of brain ischemia and clinical implications.

Inagaki T, Etgen AM.

Steroids. 2013 Jun;78(6):597-606. doi: 10.1016/j.steroids.2012.12.015. Epub 2013 Feb 4. Review.

16.

Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans.

Khanna A, Walcott BP, Kahle KT, Simard JM.

Neurosurg Focus. 2014 Jan;36(1):E11. doi: 10.3171/2013.10.FOCUS13404. Review.

17.

17β-estradiol and inflammation: implications for ischemic stroke.

Petrone AB, Simpkins JW, Barr TL.

Aging Dis. 2014 Oct 1;5(5):340-5. doi: 10.14336/AD.2014.0500340. eCollection 2014 Oct. Review.

18.

Hemorrhagic transformation after cerebral infarction: current concepts and challenges.

Zhang J, Yang Y, Sun H, Xing Y.

Ann Transl Med. 2014 Aug;2(8):81. doi: 10.3978/j.issn.2305-5839.2014.08.08. Review.

19.

Role of vasopressin and its antagonism in stroke related edema.

Ameli PA, Ameli NJ, Gubernick DM, Ansari S, Mohan S, Satriotomo I, Buckley AK, Maxwell CW Jr, Nayak VH, Shushrutha Hedna V.

J Neurosci Res. 2014 Sep;92(9):1091-9. doi: 10.1002/jnr.23407. Epub 2014 May 14. Review.

PMID:
24823792
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk